Bausch Health Companies BHC Stock
Bausch Health Companies Price Chart
Bausch Health Companies BHC Financial and Trading Overview
| Bausch Health Companies stock price | 6.69 USD |
| Previous Close | 6.03 USD |
| Open | 6 USD |
| Bid | 0 USD x 1130000 |
| Ask | 0 USD x 490000 |
| Day's Range | 5.98 - 6.92 USD |
| 52 Week Range | 4.33 - 8.69 USD |
| Volume | 16.94M USD |
| Avg. Volume | 2.81M USD |
| Market Cap | 2.58B USD |
| Beta (5Y Monthly) | 0.379 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.94 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | November 10, 2010 |
| 1y Target Est | 7.5 USD |
BHC Valuation Measures
| Enterprise Value | 22.5B USD |
| Trailing P/E | N/A |
| Forward P/E | 1.7071358 |
| PEG Ratio (5 yr expected) | 0.01 |
| Price/Sales (ttm) | 0.23742697 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.073 |
| Enterprise Value/EBITDA | 5.757 |
Trading Information
Bausch Health Companies Stock Price History
| Beta (5Y Monthly) | 0.379 |
| 52-Week Change | 19.20% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 8.69 USD |
| 52 Week Low | 4.33 USD |
| 50-Day Moving Average | 5.01 USD |
| 200-Day Moving Average | 5.84 USD |
BHC Share Statistics
| Avg. Volume (3 month) | 2.81M USD |
| Avg. Daily Volume (10-Days) | 5.8M USD |
| Shares Outstanding | 373.99M |
| Float | 260.47M |
| Short Ratio | 2.53 |
| % Held by Insiders | 11.11% |
| % Held by Institutions | 64.77% |
| Shares Short | 7.37M |
| Short % of Float | 2.46% |
| Short % of Shares Outstanding | 1.96% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 652.00% |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -10.11% |
| Operating Margin (ttm) | 27.17% |
| Gross Margin | 71.82% |
| EBITDA Margin | 36.00% |
Management Effectiveness
| Return on Assets (ttm) | 6.56% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 10.85B USD |
| Revenue Per Share (ttm) | 29.12 USD |
| Quarterly Revenue Growth (yoy) | 12.69% |
| Gross Profit (ttm) | 7.79B USD |
| EBITDA | 3.91B USD |
| Net Income Avi to Common (ttm) | -1098000000 USD |
| Diluted EPS (ttm) | -2.94 |
| Quarterly Earnings Growth (yoy) | 74.29% |
Balance Sheet
| Total Cash (mrq) | 1.82B USD |
| Total Cash Per Share (mrq) | 4.88 USD |
| Total Debt (mrq) | 20.78B USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.435 |
| Book Value Per Share (mrq) | -5.513 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.8B USD |
| Levered Free Cash Flow (ttm) | 1.43B USD |
Profile of Bausch Health Companies
| Country | United States |
| State | QC |
| City | Laval |
| Address | 2150 St. Elzéar Blvd. West |
| ZIP | H7L 4A8 |
| Phone | 514 744 6792 |
| Website | https://www.bauschhealth.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 20300 |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Q&A For Bausch Health Companies Stock
What is a current BHC stock price?
Bausch Health Companies BHC stock price today per share is 6.69 USD.
How to purchase Bausch Health Companies stock?
You can buy BHC shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bausch Health Companies?
The stock symbol or ticker of Bausch Health Companies is BHC.
Which industry does the Bausch Health Companies company belong to?
The Bausch Health Companies industry is Drug Manufacturers - Specialty & Generic.
How many shares does Bausch Health Companies have in circulation?
The max supply of Bausch Health Companies shares is 373.99M.
What is Bausch Health Companies Price to Earnings Ratio (PE Ratio)?
Bausch Health Companies PE Ratio is now.
What was Bausch Health Companies earnings per share over the trailing 12 months (TTM)?
Bausch Health Companies EPS is -2.94 USD over the trailing 12 months.
Which sector does the Bausch Health Companies company belong to?
The Bausch Health Companies sector is Healthcare.
Bausch Health Companies BHC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Composite Index
NYA
US
|
24232.46 USD — |
+0.52
|
— — | 24107.55 USD — | 24235.19 USD — | — - | — — |
|
Horizon Kinetics ISE Wealth Ind
RCH
US
|
4189.11 USD — |
-0.06
|
— — | 4162.92 USD — | 4194.53 USD — | — - | — — |
- {{ link.label }} {{link}}
